Cite
HARVARD Citation
Hruska, M. et al. (n.d.). Derivation of Phase 3 dosing for peginterferon lambda‐1a in chronic hepatitis C, Part 2: Exposure–response analyses for efficacy and safety variables. Journal of clinical pharmacology. pp. 73-80. [Online].